Adani Ports and Special Economic Zone Ltd. Achieves Outstanding Performance in the First Half of FY24

Adani Ports and Special Economic Zone Ltd. (APSEZ) announced its impressive financial results for the second quarter and the first half ending September 30, 2023, displaying substantial growth in key metrics. The company reported a strong year-over-year revenue growth of 26 per cent, reaching Rs 12,894 Crores during H1 FY24, with the Earnings Before Interest,…

Read More

Rephrase the title:SoftBank earnings Q2 FY 2023

SoftBank announces investment gain as quarterly loss continues In its fiscal second quarter, SoftBank, led by Founder Masayoshi Son, reported an investment gain on its Vision Fund, marking the second consecutive quarter of gains for the company. However, SoftBank also booked another quarterly loss, with net sales standing at 1.67 trillion Japanese yen ($11 billion)…

Read More

Hollywood Studios and SAG-AFTRA Actors’ Union Reach Tentative Labor Agreement

After 118 days of striking, Hollywood’s actors and studios have reached a preliminary labor agreement. The Screen Actors Guild-American Federation of Television and Radio Artists (SAG-AFTRA) announced that a tentative deal with the Alliance of Motion Picture and Television Producers (AMPTP) has been approved by the SAG-AFTRA TV/Theatrical Committee in a unanimous vote. The strike,…

Read More

Top Stocks with Significant Momentum in After-Hours Trading: Disney, Lyft, Arm, Duolingo, and Others

After-Hour Trading: Stocks Making Significant Moves After the bell on Tuesday, several stocks saw significant movement in after-hour trading. Some of the notable movers include: – Zoom Video Communications (ZM): The video conferencing company’s stock saw a 5% increase in after-hour trading following its earnings report. – Hewlett Packard Enterprise (HPE): HPE’s stock saw a…

Read More

The next catalyst for Eli Lilly stock could be this

Eli Lilly’s stock saw a significant increase on Wednesday after the U.S. government approved the company’s GLP-1 drug for obesity treatment. The FDA’s decision was no surprise, and now Eli Lilly is gearing up to market the drug as Zepbound. The stock price soared by almost 2% in response to the news, reaching $611.36 per…

Read More